BCYC
Price
$20.09
Change
-$1.46 (-6.77%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call
VXRT
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
Sep 22, 6:59 PM EST
46 days until earnings call

Compare trend and price BCYC vs VXRT

Header iconBCYC vs VXRT Comparison
Open Charts BCYC vs VXRTBanner chart's image
Bicycle Therapeutics
Price$20.09
Change-$1.46 (-6.77%)
Volume$77.24K
CapitalizationN/A
Vaxart
Price$0.71
Change-$0.00 (-0.00%)
Volume$429.55K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs VXRT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BCYC vs. VXRT commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and VXRT is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (BCYC: $20.09 vs. VXRT: $0.71)
Brand notoriety: BCYC and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 47% vs. VXRT: 61%
Market capitalization -- BCYC: $737.6M vs. VXRT: $108.38M
BCYC [@Biotechnology] is valued at $737.6M. VXRT’s [@Biotechnology] market capitalization is $108.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 0 green, 5 red.
According to our system of comparison, VXRT is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 3 TA indicator(s) are bullish while VXRT’s TA Score has 2 bullish TA indicator(s).

  • BCYC’s TA Score: 3 bullish, 5 bearish.
  • VXRT’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than VXRT.

Price Growth

BCYC (@Biotechnology) experienced а -3.60% price change this week, while VXRT (@Biotechnology) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

BCYC is expected to report earnings on Nov 02, 2023.

VXRT is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for VXRT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCYC($738M) has a higher market cap than VXRT($108M). VXRT YTD gains are higher at: -25.778 vs. BCYC (-32.128). VXRT has higher annual earnings (EBITDA): -92.15M vs. BCYC (-132.66M). BCYC has more cash in the bank: 340M vs. VXRT (67.9M). VXRT has less debt than BCYC: VXRT (21M) vs BCYC (47.1M). BCYC has higher revenues than VXRT: BCYC (22.5M) vs VXRT (2.06M).
BCYCVXRTBCYC / VXRT
Capitalization738M108M683%
EBITDA-132.66M-92.15M144%
Gain YTD-32.128-25.778125%
P/E RatioN/AN/A-
Revenue22.5M2.06M1,095%
Total Cash340M67.9M501%
Total Debt47.1M21M224%
FUNDAMENTALS RATINGS
VXRT: Fundamental Ratings
VXRT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCVXRT
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSPIX28.470.05
+0.18%
Victory Special Value I
PMIAX9.520.01
+0.11%
Putnam Multi-Asset Income A
FNARX43.320.03
+0.07%
Fidelity® Natural Resources Fund
TWCGX44.47-0.05
-0.11%
American Century Growth Inv
PGRVX8.33-0.04
-0.48%
Principal Global Real Estate Sec R4

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-6.77%
PHIO - BCYC
41%
Loosely correlated
-0.71%
MLTX - BCYC
39%
Loosely correlated
-1.86%
ORMP - BCYC
35%
Loosely correlated
-1.14%
SAGE - BCYC
34%
Loosely correlated
-0.20%
ALPN - BCYC
34%
Loosely correlated
-2.04%
More